The ACE2 Gateway for the COVID-19 Virus

Google+ Pinterest LinkedIn Tumblr +

The ACE2 gateway for the COVID-19 virus is a microscopic enzyme. Enzymes act as catalysts to bring about particular biochemical reactions. In this instance, the ACE2 enzyme admits both SARS-CoV and SARS-CoV-2 viruses to human body cells.

This previously harmless enzyme attaches to cell membranes in human lungs, arteries, hearts, kidneys, and intestines. After the SARS-CoV-2 virus jumped from a mammal to a human, a microscopic biochemical reaction began which we have not managed to halt.

Our Only Defense against ACE2 Gateway for the COVID-19 Virus

SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infections are medically unstoppable without a vaccine. We can only wait until our bodies develop their own immunity to the virus. Some of us may require medical support in a hospital. The fortunate majority can rest up at home while they wait for the infection to pass.

We might not have known the ACE2 gateway for the COVID-19 virus existed but for the pandemic rolling across nations. It would have simply continued with its normal duties. These comprise counterbalancing the effect of the ACE enzyme. This in turn controls our blood pressure by regulating the amount of fluids in our body.

The COVID-19 Disease Can Enter Through Any ACE2 Portal

This is the conclusion of a recent study that examined the medical records of over 70,000 patients with the illness. This research overruled the theory the illness manifests first in our upper respiratory tract, after we breathe it in. This may be why so many cases apparently go unreported, after they follow other ACE2 gateways for the COVID-19 virus.

We believe it’s essential we all understand the nature of early COVID-19 symptoms. That way, we can act responsibly, and have a better chance of not infecting other people. We will be exploring some early COVID-19 manifestations in the next couple of posts.

Related

The Many Personas of the Covid-19 Virus

New Vaccine Test in UK Brings Fresh Hope

Preview Image: Active Human ACE2 Enzyme

Share.

About Author

I have been writing about batteries and energy storage for more than ten years, and have published over 4,000 articles on this website. During that time, I have researched developments across lead-acid, lithium-ion, sodium-ion, flow batteries, and emerging energy-storage technologies. My goal is to explain complex battery concepts in clear, practical language that anyone can understand. My writing career began unexpectedly after leaving the corporate world. What started as a search for a new direction gradually became a fascination with batteries, renewable energy, and the science that powers modern life. Writing may not have made me wealthy, but it has given me the opportunity to explore an industry that continues to evolve in remarkable ways.

Leave A Reply